Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    0.00 (0.00%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Update

18 Jul 2016 07:01

RNS Number : 3909E
Transense Technologies PLC
18 July 2016
 

18 July 2016

Transense Technologies Plc

("Transense" or "the Company")

Trading Update

Transense Technologies Plc (AIM: TRT), the provider of sensor systems for the transportation and industrial markets, provides a trading update relating to the financial year ended 30 June 2016.

Trading update

The company reported that the sale of IntelliSaw to Emerson in October 2015, with the associated limited scope licensing of core Surface Acoustic Wave ("SAW") sensor technology, provided a strong signal to the industrial marketplace of the increasing maturity and value of this expertise. Progress towards commercialisation of SAW across several other applications has been steady throughout the second half of the year. This has become evident through the successful product launch by a major European customer in April 2016, and the post year-end signing of a licensing agreement in partnership with GE announced today. In the short term, SAW revenue generation is not a key value driver, however the board are pleased to note that sales for the full year did finish broadly in line with expectations.

The rate of revenue growth in Translogik continues to be held back by difficult market conditions in the mining sector. Several live trials are in progress and demonstrating good results, but decision making timescales continue to be elongated by financial and other constraints. Meanwhile, there has been an upturn in the rate of sales of tyre probe products in the second half of the year, which is encouraging.

Overall, trading results for the year ended 30 June 2016 are expected to be in line with the board's expectations as revised on the release of the interim results in March, with revenues of approximately £2M, and closing cash balances of £3.6M.

 

Capital structure

The board has taken advice on steps which may be taken to eliminate the accumulated deficit on reserves through a capital restructuring exercise and intends to bring proposals forward at the Annual General Meeting later this year.

 

 

For further information please visit www.transense.co.uk or contact:

 

Transense Technologies Plc

Graham Storey, Chief Executive

 

Tel: +44 (0) 1869 238380

 

finnCap

Ed Frisby, Giles Rolls (Corporate Finance)

Tony Quirke, Alice Lane (Corporate Broking)

 

Tel: +44 (0) 20 7220 0500

 

IFC Advisory

Tim Metcalfe, Graham Herring, Heather Armstrong

 

Tel: +44 (0) 20 3053 8671

 

 

 

About Transense Technologies

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense.

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT).

www.transense.co.uk

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKODNFBKDPOD
Date   Source Headline
16th Jan 20082:47 pmRNSHolding(s) in Company
4th Jan 200812:08 pmRNSResult of General Meeting
13th Dec 200710:08 amRNSGrant of Options
10th Dec 200712:56 pmRNSFurther update
7th Dec 20078:00 amRNSAdditional Listing
3rd Dec 200712:18 pmRNSProposed Directorate Changes
21st Nov 20077:30 amRNSRestoration - Transense Techn
21st Nov 20077:30 amRNSFurther Update
20th Nov 200712:14 pmRNSHolding(s) in Company
16th Nov 20073:51 pmRNSResult of EGM
16th Nov 20073:51 pmRNSSuspension - Transense Tech
16th Nov 200710:47 amRNSHolding(s) in Company
15th Nov 20077:03 amRNSGeneral Meeting update
13th Nov 20073:58 pmRNSSchedule 1 - Transense Techno
13th Nov 20077:00 amRNSGeneral Meeting update
2nd Nov 20075:51 pmRNSSchedule 1 - Transense Techno
2nd Nov 200712:53 pmRNSConference Call
26th Oct 20077:30 amRNSConference call
24th Oct 200711:02 amRNSHolding(s) in Company
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company
11th Oct 200710:34 amRNSStatement re. Suspension
11th Oct 200710:30 amRNSSuspension - Transense Tech.
28th Sep 20077:03 amRNSInterim Results
25th Sep 20074:25 pmRNSHolding(s) in Company
9th Aug 200711:44 amRNSAIM Rule 26 Compliance
8th Aug 200712:11 pmRNSPatent Agreement
20th Jun 20073:45 pmRNSDirector/PDMR Shareholding
12th Jun 20073:39 pmRNSTotal Voting Rights
25th May 20073:10 pmRNSAGM Statement
24th May 200711:30 amRNSAGM Statement
10th May 20076:04 pmRNSDirector/PDMR Shareholding
19th Apr 20078:00 amRNSDirector/PDMR Shareholding
17th Apr 200710:29 amRNSDirector Resignation
11th Apr 200712:17 pmRNSDirector/PDMR Shareholding
10th Apr 20074:16 pmRNSHolding(s) in Company
30th Mar 20077:03 amRNSFinal Results
14th Mar 20073:49 pmRNSHolding(s) in Company
8th Mar 20072:59 pmRNSHolding(s) in Company
1st Mar 20075:32 pmRNSHolding(s) in Company
26th Feb 20074:14 pmRNSHolding(s) in Company
22nd Feb 20072:20 pmRNSHolding(s) in Company
22nd Feb 20072:15 pmRNSHolding(s) in Company
14th Feb 20074:05 pmRNSHolding(s) in Company
15th Jan 20075:51 pmRNSHolding(s) in Company
10th Jan 20071:45 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSRe Agreement
27th Nov 20067:01 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.